Evidence map›Paper›PMID 42162297›Full record

ReviewNature medicine2026

Global approaches to infectious disease surveillance and modeling.

Mark P Khurana, Joseph L-H Tsui, Bernardo Gutierrez, Ayush Chopra, Neil Scheidwasser, Harrison Bo Hua Zhu, Serina Y Chang, David A Duchêne, Cathal Mills, Rhys P D Inward and 39 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors.

Mark P Khurana *Section for Health Data Science and AI, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-1123-7674
Joseph L-H Tsui *Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Bernardo Gutierrez *Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-9220-2739
Ayush ChopraMIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA.
Neil ScheidwasserSection for Health Data Science and AI, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Harrison Bo Hua ZhuSection for Health Data Science and AI, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Serina Y ChangDepartment of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, CA, USA.
David A DuchêneSection for Health Data Science and AI, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Cathal MillsDepartment of Statistics, University of Oxford, Oxford, UK.
Rhys P D InwardPandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-0016-661X
Benjamin ReddyPandemic Sciences Institute, University of Oxford, Oxford, UK.
John BrittainPandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-4172-190X
Abhishek DasguptaPandemic Sciences Institute, University of Oxford, Oxford, UK.
James SheldonInstitute for Experiential AI, Northeastern University, Boston, MA, USA.
George GithinjiKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.ORCID http://orcid.org/0000-0001-9640-7371
John S BrownsteinComputational Epidemiology Lab, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8568-5317
Mélodie MonodCEREMADE, CNRS, Université Paris Dauphine, Université PSL, Paris, France.
Luca FerrettiPandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7578-7301
Sivan BershanExago.ml, Berlin, Germany.
Simon TietzeExago.ml, Berlin, Germany.
Leo FerresInstitute of Data Science, Faculty of Engineering, Universidad del Desarrollo, Santiago, Chile.ORCID http://orcid.org/0000-0002-5899-9051
Silvia ArgimónWHO Hub for Pandemic and Epidemic Intelligence, Health Emergencies Programme, World Health Organization, Berlin, Germany.
Timothy J DallmanWHO Hub for Pandemic and Epidemic Intelligence, Health Emergencies Programme, World Health Organization, Berlin, Germany.
Etien KouaWorld Health Organization Regional Office for Africa, Brazzaville, Congo.
Oliver RatmannDepartment of Mathematics, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-8667-4118
Simon CauchemezMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, INSERM U1332, CNRS UMR 2000, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0001-9186-4549
Lauren A MeyersDepartment of Integrative Biology, University of Texas at Austin, Austin, TX, USA.
Lili SuDepartment of Electrical and Computer Engineering, Northeastern University, Boston, MA, USA.
Alessandro VespignaniInstitute for Scientific Interchange Foundation, Turin, Italy.ORCID http://orcid.org/0000-0003-3419-4205
Paul PronykCentre for Outbreak Preparedness, Duke-NUS Medical School, Singapore, Singapore.
Áine O'TooleInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0001-8083-474X
Andrew RambautInstitute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-4337-3707
Nicholas J LomanInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Edward C HolmesSchool of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0001-9596-3552
Seth FlaxmanDepartment of Computer Science, University of Oxford, Oxford, UK.
Nicola MulderComputational Biology Division, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa.ORCID http://orcid.org/0000-0003-4905-0941
Oliver W MorganWHO Hub for Pandemic and Epidemic Intelligence, Health Emergencies Programme, World Health Organization, Berlin, Germany.ORCID http://orcid.org/0000-0002-9543-3778
Houriiyah TegallyCentre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.ORCID http://orcid.org/0000-0002-7102-8540
Manuel Gomez-RodriguezMax Planck Institute for Software Systems, Kaiserslautern, Germany.ORCID http://orcid.org/0000-0003-3930-1161
Nigel ShadboltDepartment of Computer Science, University of Oxford, Oxford, UK.
Christian HappiInstitute of Genomics and Global Health, Redeemer's University, Ede, Nigeria.ORCID http://orcid.org/0000-0002-3056-6705
Meera ChandUK Health Security Agency, London, UK.
Sofonias K TessemaAfrica Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia.ORCID http://orcid.org/0000-0003-1057-5310
Placide Mbala-KingebeniInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.ORCID http://orcid.org/0000-0003-1556-3570
Marc A SuchardDepartment of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9818-479X
Oliver G PybusPandemic Sciences Institute, University of Oxford, Oxford, UK.
Samuel V ScarpinoInstitute for Experiential AI, Northeastern University, Boston, MA, USA. s.scarpino@northeastern.edu.ORCID http://orcid.org/0000-0001-5716-2770
Samir BhattSection for Health Data Science and AI, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. samir.bhatt@sund.ku.dk.
Moritz U G KraemerPandemic Sciences Institute, University of Oxford, Oxford, UK. moritz.kraemer@biology.ox.ac.uk.ORCID http://orcid.org/0000-0001-8838-7147

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human mobility, climate change and demographic trends increase the risk of pathogen spillover and expansion. Data that can inform our responses to outbreaks have increased in availability and volume, but access to highly confidential outbreak data and commercially sensitive contextual information remains difficult. Despite ongoing efforts to adopt global health data infrastructures and sharing protocols, there remain regulatory, logistical, human and computational barriers to data sharing. Federated approaches-in which data remain stored locally but analyses are performed across datasets from different sources-offer a potential way to address these challenges. While federated approaches have been used in some clinical and biomedical contexts, their adoption in infectious disease surveillance and modeling has been limited. Here, we discuss global approaches to infectious disease modeling and analysis, with a focus on federated methods. We outline how these can be used to address key epidemiological questions during outbreaks by enabling the secure use of multimodal data and integration with existing surveillance and modeling efforts. We summarize current methods for combining distributed and locally stored data and identify limitations, opportunities and organizational structures needed to achieve equitable global public health impacts.

Indexed as

Communicable DiseasesPopulation SurveillanceDisease OutbreaksGlobal HealthHumansInformation Dissemination

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.